Thus, while early and presymptomatic stages, characterized by neuronal malfunctioning, are associated with downregulation of CB1, advanced stages of parkinsonism, characterized by a profound nigral degeneration, are associated with upregulatory responses of CB1, and possibly CB2 too (García-Arencibia et al., 2009). The gene discussed is CNR1; the disease is Parkinsonism.